FHI 360’s “R&E Search for Evidence”: What is the global health community saying about the ECHO trial results?
Corey White, managing editor of R&E Search for Evidence and communications specialist in the Chief Science Office at FHI 360, discusses the history and results of the ECHO (Evidence for Contraceptive Options and HIV Outcomes) trial, which studied whether the birth control method Depo Provera, along with two other methods, increased women’s risk of contracting HIV. White also highlights the global health community’s reaction to the results (7/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.